Literature DB >> 9169607

Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

H J Brinkman1, P Koster, K Mertens, J A van Mourik.   

Abstract

A localized and regulated cascade of proteolytic events is a prerequisite for normal haemostasis. The activation of factor X by activated factor IX (factor IXa) in the presence of activated factor VIII (factor VIIIa) is essential for the formation of a fibrin clot at sites of vascular injury. We observed sustained activation of factor X on the surface of vascular endothelial cells, whereas, in agreement with others, on synthetic negatively charged phospholipid vesicles and activated blood platelets factor X activation is transient and starts to decline a few minutes after the onset of the reaction. We examined the mechanism responsible for these differences in factor X activation. Procoagulant membrane and solution were analysed separately for the occurrence of factor VIII and its activation fragments. On negatively charged phospholipid vesicles, on dissociation of factor VIIIa, the 67 kDa light-chain fragment remains associated with the lipid membrane. As a result, factor VIII-binding sites remain occupied, and dampening of factor X activation occurs. In contrast, on monolayers of endothelial cells, no residual factor VIIIa fragments associated with the cell membrane were observed. During endothelial-cell-mediated activation of factor X, accumulation of factor VIIIa fragments was observed in the solution phase only. This finding suggests that, on endothelial cells, factor VIII-binding sites remain accessible for further factor VIII binding, guaranteeing sustained activation of factor X. These data demonstrate that the nature of the procoagulant membrane contributes to the regulation of the cofactor activity of factor VIII and thereby affects the progress of factor X activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169607      PMCID: PMC1218377          DOI: 10.1042/bj3230735

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine.

Authors:  G E Gilbert; A A Arena
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

2.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

3.  Binding of factors IX and IXa to cultured vascular endothelial cells.

Authors:  D M Stern; M Drillings; H L Nossel; A Hurlet-Jensen; K S LaGamma; J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

4.  Activation of human coagulation factor VIII by activated factor X, the common product of the intrinsic and the extrinsic pathway of blood coagulation.

Authors:  K Mertens; R M Bertina
Journal:  Thromb Haemost       Date:  1982-04-30       Impact factor: 5.249

5.  Role of human factor VIII in factor X activation.

Authors:  M B Hultin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

Authors:  K Mertens; R Cupers; A Van Wijngaarden; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

7.  The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

8.  Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein.

Authors:  D N Fass; G J Knutson; J A Katzmann
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

9.  Binding of coagulation factors IX and X to the endothelial cell surface.

Authors:  R L Heimark; S M Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1983-03-16       Impact factor: 3.575

10.  The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombin.

Authors:  M B Hultin; J Jesty
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

View more
  1 in total

1.  A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.

Authors:  Esther Bloem; Henriet Meems; Maartje van den Biggelaar; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.